SCHEDULE: Aikawa Equity Management Discloses 5.2% Stake in SBC Medical

Aikawa Equity Management Co., Ltd. has reported a 5.2% beneficial ownership stake in SBC Medical Group Holdings Inc., acquiring 5,284,500 shares of common stock.

Summary

• Aikawa Equity Management Co., Ltd. (Aikawa Equity Management) reported beneficial ownership of 5,284,500 shares of Common Stock in SBC Medical Group Holdings Inc.
• This represents 5.2% of the Issuer's outstanding Common Stock.
• The shares were acquired pursuant to a subscription agreement dated December 23, 2025, between Dr. Yoshiyuki Aikawa, Chief Executive Officer of the Issuer, and Aikawa Equity Management.
• As of March 6, 2026, Dr. Aikawa ceased to have sole voting and dispositive power over the Common Stock held by Aikawa Equity Management.
• The percentage of class is based on 102,576,943 shares of Common Stock outstanding on December 26, 2025, as disclosed in the Issuer's prospectus filed on January 5, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as a significant 5.2% stake acquisition by Aikawa Equity Management Co., Ltd. signals investor confidence in SBC Medical Group Holdings Inc., although the filing itself is a routine disclosure of ownership.

Positives

• Aikawa Equity Management Co., Ltd. has acquired a significant 5.2% stake in SBC Medical Group Holdings Inc., indicating a notable investment and potential confidence in the company's future.

Negatives

• NA

Risks

• NA

Future Outlook

Aikawa Equity Management Co., Ltd. has entered into agreements with certain consultants providing services to medical corporations that have contractual arrangements with subsidiaries of the Issuer. These consultants have acquired equity interests in Aikawa Equity Management Co., Ltd. and possess the right to redeem those interests in exchange for proceeds from the future sale of Common Stock held by the Reporting Person, subject to specific terms.

Management Comments

• NA

Industry Context

StockSavvy.ai notes that this Schedule 13G filing indicates a significant ownership stake by a Japanese entity, Aikawa Equity Management Co., Ltd., in a U.S.-listed medical group. Such filings are routine for investors crossing the 5% ownership threshold and often signal a long-term investment perspective rather than an activist stance, especially given the nature of a 13G filing. The transfer of control over these specific shares from the CEO to the entity could be part of a broader corporate restructuring or a mechanism for employee/consultant incentives.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• The Reporting Person acquired Common Stock pursuant to a subscription agreement dated December 23, 2025, between Dr. Yoshiyuki Aikawa, Chief Executive Officer of the Issuer, and the Reporting Person.

Stakeholder Impact

• Shareholders: A new significant institutional investor, Aikawa Equity Management Co., Ltd., now holds 5.2% of the common stock, potentially influencing market perception and liquidity.
• Consultants: Certain consultants providing services to medical corporations affiliated with the Issuer have acquired equity interests in Aikawa Equity Management Co., Ltd., providing them with a vested interest in the performance of the Reporting Person's holdings.

Next Steps

• Consultants who acquired equity interests in Aikawa Equity Management Co., Ltd. have the right to redeem those interests for proceeds from the future sale of Common Stock held by the Reporting Person, subject to the terms of such interests.

Key Dates

Keywords

SBC Medical Group Holdings Inc, Aikawa Equity Management, Schedule 13G, beneficial ownership, common stock, equity stake, investment, corporate governance